Provided by Tiger Trade Technology Pte. Ltd.

GT Biopharma Inc.

7.81
-1.1900-13.22%
Post-market: 7.810.00000.00%16:10 EDT
Volume:106.97K
Turnover:850.11K
Market Cap:14.09M
PE:-0.59
High:9.04
Open:9.04
Low:7.31
Close:9.00
52wk High:34.25
52wk Low:4.91
Shares:1.80M
Float Shares:1.70M
Volume Ratio:0.32
T/O Rate:6.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-13.2195
EPS(LYR):-156.2099
ROE:-113.52%
ROA:-158.16%
PB:3.95
PE(LYR):-0.05

Loading ...

GT Biopharma Announces Potential New Indication for Gtb-5550, a B7-H3-Targeted Natural Killer (Nk) Cell Engager, for Multiple Myeloma

THOMSON REUTERS
·
Sep 15

GT Biopharma - FDA Clears Ind for Gtb-5550 in Multiple Myeloma

THOMSON REUTERS
·
Sep 15

GT Biopharma - Phase 1 Trial with Gtb-5550 in Solid Tumors Actively Enrolling, Update Expected Q4 2026

THOMSON REUTERS
·
Sep 15

GT Biopharma to Host Live Company Presentation on the Development of TriKE® Platform for Cancer Treatment, September 11, 2026

GlobeNewswire
·
Sep 11

GT Biopharma trading halted, news pending

TIPRANKS
·
Sep 05

GT Biopharma (GTBP) Gets a Buy from Roth MKM

TIPRANKS
·
Aug 18

GT Biopharma Holds Annual Shareholder Meeting

Reuters
·
Aug 15

GT Biopharma Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

Gt Biopharma Reports Second Quarter 2026 Financial Results

Reuters
·
Aug 14

GT Biopharma Q2 FY26 Net Loss Narrows to $4.5 Million; Operating Loss Widens to $4.5 Million

Reuters
·
Aug 14

GT Biopharma Inc - Cash Balance as of June 30, of About $5.1 Mln Anticipated to Provide Sufficient Cash Runway Through Q4 2026

THOMSON REUTERS
·
Aug 14

GT Biopharma Reports Second Quarter 2026 Financial Results

GlobeNewswire
·
Aug 14

GT Biopharma Inc Expected to Post a Loss of 8 Cents a Share - Earnings Preview

Reuters
·
Aug 11

GT Biopharma announces annual shareholder meeting

Reuters
·
Jun 19

GT Biopharma lowers shareholder meeting quorum threshold to one-third of outstanding shares

Reuters
·
Jun 13

GT Biopharma expects multiple AI-driven development candidates to enter pre-IND stage in 2027

Reuters
·
Jun 01

GT Biopharma - Increases AI Integration to Accelerate Development and Reduce Costs

THOMSON REUTERS
·
Jun 01

GT Biopharma Provides Update on Pipeline Discovery Activities From Newly Implemented AI-Based Technological Initiatives

THOMSON REUTERS
·
Jun 01

GT Biopharma - to Expand Pipeline Targets Beyond Oncology in 2027

THOMSON REUTERS
·
Jun 01

GT Biopharma Provides Update on Pipeline Discovery Activities from Newly Implemented AI-Based Technological Initiatives

GlobeNewswire
·
Jun 01